<DOC>
	<DOCNO>NCT01041287</DOCNO>
	<brief_summary>Hypertension , high blood pressure , common disease affect many Americans , lead devastate consequence heart attack , stroke , death treat . Nebivolol medication recently approve FDA treatment hypertension . Nebivolol unusual profile compare medication , effect may relate release substance call nitric oxide . Nitric oxide release cell line blood vessel , nebivolol may stimulate cell release nitric oxide . Our study investigate whether treatment nebivolol , compare another medication call metoprolol , hypertensive subject effective protect blood vessel harmful effect high blood pressure . The mechanisms investigate include oxidative stress marker circulate level endothelial progenitor cell .</brief_summary>
	<brief_title>Effect Nebivolol Oxidative Stress Endothelial Progenitor Cells</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>1 . Males postmenopausal female age 2180 year . 2 . Hypertensive patient ( BP &gt; 135/85 ) eligible participate . 3 . Patients current antihypertensive therapy include beta blockade BP &gt; 135/85 . 4 . Patients antihypertensive therapy include beta blockade beta blocker discontinue gradually 2 week enrolment . 5 . Concomitant therapy : Patients allow comcomitant therapy aspirin , statin , thiazide diuretic , calcium antagonist ( treatment hypertension ) , clonidine , vasodilator , angiotensin antagonist . Patients stable medical therapy least 2 month recruitment . Patients previous treatment beta adrenergic blocker ( metoprolol , propranolol , atenolol , labetalol ) also eligible participate , randomize study beta blocker . 1 . Age &lt; 21 &gt; 80 year 2 . Initiation change dose statin antihypertensive therapy within 2 month study 3 . Premenopausal females potential pregnancy 4 . Acute infection previous 2 week 5 . History substance abuse 6 . Current neoplasm 7 . Chronic renal failure [ creatinine &gt; 2.5 mg/dL ] liver failure ( Liver enzymes &gt; 2X normal ) 8 . Acute coronary syndrome , Class IV heart failure , CVA , coronary intervention within 2 month 9 . Known aortic stenosis , hypertrophic cardiomyopathy . 10 . Inability give inform consent 11 . Inability return Emory followup test</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>